BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7886587)

  • 1. Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever.
    Butthep P; Bunyaratvej A; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():246-9. PubMed ID: 7886587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three possible triggers to induce thrombocytopenia in dengue virus infection.
    Funahara Y; Ogawa K; Fujita N; Okuno Y
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):351-5. PubMed ID: 3433166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia in patients with dengue virus infection in the Brazilian Amazon.
    Mourão MP; Lacerda MV; Macedo VO; Santos JB
    Platelets; 2007 Dec; 18(8):605-12. PubMed ID: 18041652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
    Lin CF; Lei HY; Shiau AL; Liu CC; Liu HS; Yeh TM; Chen SH; Lin YS
    J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia in dengue fever.
    Schexneider KI; Reedy EA
    Curr Hematol Rep; 2005 Mar; 4(2):145-8. PubMed ID: 15720964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP cellular responses to dengue virus infection-induced vascular leakage.
    Luplertlop N; Missé D
    Jpn J Infect Dis; 2008 Jul; 61(4):298-301. PubMed ID: 18653973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator induced by dengue virus infection of human endothelial cells.
    Huang YH; Lei HY; Liu HS; Lin YS; Chen SH; Liu CC; Yeh TM
    J Med Virol; 2003 Aug; 70(4):610-6. PubMed ID: 12794725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in severe dengue viral infection: association of thrombocytopenia with lipid peroxidation.
    Soundravally R; Sankar P; Bobby Z; Hoti SL
    Platelets; 2008 Sep; 19(6):447-54. PubMed ID: 18925513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glance at the von Willebrand factor in dengue virus infection.
    Basuki PS
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):559-63. PubMed ID: 15115128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of vascular damage in dengue disease: demonstration of high levels of soluble cell adhesion molecules and circulating endothelial cells.
    Cardier JE; Rivas B; Romano E; Rothman AL; Perez-Perez C; Ochoa M; Caceres AM; Cardier M; Guevara N; Giovannetti R
    Endothelium; 2006; 13(5):335-40. PubMed ID: 17090406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
    Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
    J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of dengue virus infection on the production of ET-1 and PGI2 by human vascular endothelial cells].
    Jiang L; Guo H; Fang D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Sep; 13(3):239-42. PubMed ID: 12569754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers.
    Carr JM; Hocking H; Bunting K; Wright PJ; Davidson A; Gamble J; Burrell CJ; Li P
    J Med Virol; 2003 Apr; 69(4):521-8. PubMed ID: 12601760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study.
    Seet RC; Chow AW; Quek AM; Chan YH; Lim EC
    Int J Infect Dis; 2009 Sep; 13(5):e248-53. PubMed ID: 19261502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome.
    Butthep P; Chunhakan S; Tangnararatchakit K; Yoksan S; Pattanapanyasat K; Chuansumrit A
    Pediatr Infect Dis J; 2006 Oct; 25(10):894-7. PubMed ID: 17006283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in thrombopoiesis in patients with thrombocytopenia produced by dengue hemorrhagic fever.
    Putintseva E; Vega G; Fernández L
    Nouv Rev Fr Hematol (1978); 1986; 28(5):269-73. PubMed ID: 3808936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus regulates the expression of hemostasis-related molecules in human vein endothelial cells.
    Jiang Z; Tang X; Xiao R; Jiang L; Chen X
    J Infect; 2007 Aug; 55(2):e23-8. PubMed ID: 17573116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J; Gu F; Vasudevan SG
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis.
    Avirutnan P; Malasit P; Seliger B; Bhakdi S; Husmann M
    J Immunol; 1998 Dec; 161(11):6338-46. PubMed ID: 9834124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal hemostasis in dengue hemorrhagic fever.
    Hathirat P; Isarangkura P; Srichaikul T; Suvatte V; Mitrakul C
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():80-5. PubMed ID: 7886614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.